Skip to main content

Protective Effects of Calcium Antagonists on Vitamin-Induced Nephrolithiasis

  • Chapter
Urolithiasis 2
  • 18 Accesses

Abstract

The active vitamin D, 1,25-dihydroxycholecalciferol (DHCC), plays an important role in the pathogenesis of calcium urolithiasis. Increased 1,25-DHCC levels are found in 30 – 80 % of hypercalciuric patients1-3. The underlying mechanisms, however, are not understood completely. In an experimental study we investigated whether cellular processes are important for the pathogenesis of vitamin D-induced nephrolithiasis and whether cytoprotective drugs as calcium antagonists can influence these processes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. K-H Bichler, WL Strohmaier, M Schreiber, S Korn and I Gaiser, Hyperkalziurie und Vitamin D-Stoffwechsel. Fortschr UrolNephrol 22: 342 (1984).

    Article  Google Scholar 

  2. KL Insogna, AE Broadus, BE Dreyer, AS Ellison and JM Gertner, Elevated production rate of 1,25-dihydroxy vitamin D in patients with absorptive hypercalciuria, J Clin Endocrinol Metab 61: 490 (1985).

    Article  PubMed  CAS  Google Scholar 

  3. FB Stapleton, CB Langman, J Bittle and LA Miller, Increased serum concentrations of 1,25 (OH)2 vitamin D in children with fasting hypercalciuria, J Pediatr 110: 234 (1987).

    Article  PubMed  CAS  Google Scholar 

  4. H Oßwald, W Steinbrecher, G Weinheimer, B Wagner, J Kleinschroth, J Hartenstein and G Satzinger, Antihypertensive activity of a novel calcium antagonist, Goe 5584-A, in rat models of hypertension, J Cardiovasc Pharmacol 12II, suppl.6: 154 (1988).

    Google Scholar 

  5. K-H Bichler, WL Strohmaier in: “Nephrocalcinosis, Calcium Antagonists and Kidney” Springer, Berlin (1988).

    Book  Google Scholar 

  6. T Weinreich, J Merke, M Schonermark, H Reichel, M Diebold, GM Haensch and E Ritz, Actions of 1,25-dihydroxyvitamin D3 on human mesangial cells, Am J Kidney Dis 18: 359 (1991).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer Science+Business Media New York

About this chapter

Cite this chapter

Strohmaier, W.L., Seeger, R.D., Oßwald, H., Bichler, KH. (1994). Protective Effects of Calcium Antagonists on Vitamin-Induced Nephrolithiasis. In: Ryall, R., Bais, R., Marshall, V.R., Rofe, A.M., Smith, L.H., Walker, V.R. (eds) Urolithiasis 2. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2556-1_245

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-2556-1_245

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6091-9

  • Online ISBN: 978-1-4615-2556-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics